Stocktoria
BGM Group Ltd. BGM
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-01-12
BGM Group Ltd. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Gross margin | 16.4% | 3.8% | 9.6% | 9.9% | 15.1% |
| Operating margin | -2.2% | -5.6% | 3.2% | 4.2% | 9.6% |
| Net margin | -5.7% | -16.7% | 1.7% | 5.5% | 10.1% |
| FCF margin | 1.2% | 0.3% | 16.4% | -2.0% | 9.2% |
| Return on assets | -2.7% | -15.2% | 1.7% | 4.2% | 10.5% |
| Return on equity | -3.3% | -17.5% | 2.0% | 5.6% | 17.6% |
| Current ratio | 3.39 | 5.18 | 3.27 | 2.22 | 2.04 |
| Revenue growth | -46.0% | -28.3% | 13.6% | 14.1% | — |
Source: SEC EDGAR filings · CIK 0001779578 · as of 2024-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.